Relative difference | p-value | Relative difference | p-value | |
---|---|---|---|---|
(AXB2.5 -AAA2.5)/ AAA2.5×100% | (AXB1.0 - AXB2.5)/ AXB2.5×100% | |||
Average ± SDV (min-max) | Average ± SDV (min-max) | |||
Stage I (N = 8) | ||||
PTV | ||||
D98% | −3.2% ± 4.0% (−12.3% – 0.5%) | 0.06 | 0.7% ± 1.3% (−0.8% – 3.1%) | 0.19 |
D2% | 0.2% ± 1.2% (−2.1% – 1.3%) | 0.69 | 0.9% ± 0.4% (0.3% – 1.4%) | <0.01* |
Dmean | −0.6% ± 2.2% (−4.9% – 1.6%) | 0.46 | 0.2% ± 0.5% (−0.6% – 1.2%) | 0.45 |
Total lung | ||||
V5Gy | 1.3% ± 1.9% (−1.9% –3.2%) | 0.12 | 0.1% ± 0.6% (−0.8% – 1.1%) | 0.73 |
V20Gy | 2.0% ± 2.3% (0.0% – 5.7%) | 0.05* | −0.7% ± 1.2% (−2.7% – 0.0%) | 0.17 |
MLD | 0.0% ± 0.5% (−0.7% – 0.7%) | 0.60 | 0.1% ± 0.2% (0.0% – 0.4%) | 0.08 |
Time | ||||
Calculation | −39.2% ± 13.5% (−50.3% – –8.2%) | <0.01* | 304.7% ± 48.7% (226.9% – 345.8%) | <0.01* |
Stage III (N = 7) | ||||
PTV | ||||
D98% | −0.3% ± 0.7% (−0.8% – 1.3%) | 0.33 | 0.2% ± 0.8% (−1.4% – 0.9%) | 0.57 |
D2% | −0.6% ± 2.0% (−2.1% – 3.0%) | 0.47 | 0.6% ± 0.4% (−0.1% – 1.0%) | <0.01* |
Dmean | −0.8% ± 0.7% (−1.6% – 0.3%) | 0.02* | 0.1% ± 0.3% (−0.5% – 0.4%) | 0.40 |
Total lung | ||||
V5Gy | −1.8% ± 1.7% (−4.8% – 0.3%) | 0.03* | −0.4% ± 0.7% (−1.5% – 0.4%) | 0.16 |
V20Gy | 0.2% ± 0.7% (−0.5% – 1.5%) | 0.69 | 0.0% ± 0.0% (0.0% –0.0%) | 1.00 |
MLD | −0.5% ± 0.6% (−1.3% – 0.0%) | 0.09 | 0.2% ± 0.3% (0.0% – 0.6% ) | 0.17 |
Time | ||||
Calculation | −31.4% ± 9.9% (−44.4% – –17.9%) | <0.01* | 556.9% ± 91.1% (412.3% – 646.0%) | <0.01* |